chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Lung opacity, Mechanical ventilation, Metabolic function test, Neurological examination abnormal, Platelet count decreased
Clinical narrative: 46 year old female, presented with syncope and SOB with exertion associated with dizziness. She developed agonal breathing and PEA arrest. She was intubated and ACLS protocol was initiated. Lucas device was placed. Cath lab was contacted as well as surgical critical care attending. Decision was made to place patient on ECMO and she was transferred to the cath lab for further management. While in the cath lab, she was placed on VA ECMO via right femoral vessels. She was found to have a large saddle PE and occlusive Right PA pulmonary embolism and large clot burden in the left PA.  She underwent flow retriever with improvement in clot burden. She has significant OGT output with bloody output as well as evidence of lower GI bleed. She had a large hematoma in the left groin. She was started on epi 0.2, levo 0.3 and vaso 0.04. Vasopressin was increased to 0.08. She was resuscitated with blood products given profound anemia and coagulopathy. Her pressor requirement decreased slightly. Her neurologic exam was questionable with no movement to noxious stimuli. Her pupils were weakly reactive. She did not have a gag or cough reflex. She was breathing over the ventilator. Over the course of the next few hours, she continued to have significant pressor requirements and evidence of ongoing blood loss through her GI tract and Left  groin. She had a significant lactic acidosis that did not improve. CVVHD was initiated. Suddenly, her VA ECMO flows decreased significantly and venous pressures were high. The ECMO circuit was clamped and the venous cannula was interrogated. There was no flow from the venous cannula despite repositioning. She had evidence of mottling in her right lower extremity to her abdomen concerning for clot through the IVC. Given the suspected clot burden and lack of neurologic activity, further resuscitation was deemed futile. Family was contacted and patient was made CMO.  She subsequently expired 3/21 at 0455.
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pleural effusion, Pulmonary artery thrombosis, Pulmonary embolism, Pulseless electrical activity, Pupillary light reflex tests abnormal
Clinical narrative: 46 year old female, presented with syncope and SOB with exertion associated with dizziness. She developed agonal breathing and PEA arrest. She was intubated and ACLS protocol was initiated. Lucas device was placed. Cath lab was contacted as well as surgical critical care attending. Decision was made to place patient on ECMO and she was transferred to the cath lab for further management. While in the cath lab, she was placed on VA ECMO via right femoral vessels. She was found to have a large saddle PE and occlusive Right PA pulmonary embolism and large clot burden in the left PA.  She underwent flow retriever with improvement in clot burden. She has significant OGT output with bloody output as well as evidence of lower GI bleed. She had a large hematoma in the left groin. She was started on epi 0.2, levo 0.3 and vaso 0.04. Vasopressin was increased to 0.08. She was resuscitated with blood products given profound anemia and coagulopathy. Her pressor requirement decreased slightly. Her neurologic exam was questionable with no movement to noxious stimuli. Her pupils were weakly reactive. She did not have a gag or cough reflex. She was breathing over the ventilator. Over the course of the next few hours, she continued to have significant pressor requirements and evidence of ongoing blood loss through her GI tract and Left  groin. She had a significant lactic acidosis that did not improve. CVVHD was initiated. Suddenly, her VA ECMO flows decreased significantly and venous pressures were high. The ECMO circuit was clamped and the venous cannula was interrogated. There was no flow from the venous cannula despite repositioning. She had evidence of mottling in her right lower extremity to her abdomen concerning for clot through the IVC. Given the suspected clot burden and lack of neurologic activity, further resuscitation was deemed futile. Family was contacted and patient was made CMO.  She subsequently expired 3/21 at 0455.
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Resuscitation, SARS-CoV-2 test negative, Syncope, Thrombectomy, Troponin
Clinical narrative: 46 year old female, presented with syncope and SOB with exertion associated with dizziness. She developed agonal breathing and PEA arrest. She was intubated and ACLS protocol was initiated. Lucas device was placed. Cath lab was contacted as well as surgical critical care attending. Decision was made to place patient on ECMO and she was transferred to the cath lab for further management. While in the cath lab, she was placed on VA ECMO via right femoral vessels. She was found to have a large saddle PE and occlusive Right PA pulmonary embolism and large clot burden in the left PA.  She underwent flow retriever with improvement in clot burden. She has significant OGT output with bloody output as well as evidence of lower GI bleed. She had a large hematoma in the left groin. She was started on epi 0.2, levo 0.3 and vaso 0.04. Vasopressin was increased to 0.08. She was resuscitated with blood products given profound anemia and coagulopathy. Her pressor requirement decreased slightly. Her neurologic exam was questionable with no movement to noxious stimuli. Her pupils were weakly reactive. She did not have a gag or cough reflex. She was breathing over the ventilator. Over the course of the next few hours, she continued to have significant pressor requirements and evidence of ongoing blood loss through her GI tract and Left  groin. She had a significant lactic acidosis that did not improve. CVVHD was initiated. Suddenly, her VA ECMO flows decreased significantly and venous pressures were high. The ECMO circuit was clamped and the venous cannula was interrogated. There was no flow from the venous cannula despite repositioning. She had evidence of mottling in her right lower extremity to her abdomen concerning for clot through the IVC. Given the suspected clot burden and lack of neurologic activity, further resuscitation was deemed futile. Family was contacted and patient was made CMO.  She subsequently expired 3/21 at 0455.
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: White blood cell count increased
Clinical narrative: 46 year old female, presented with syncope and SOB with exertion associated with dizziness. She developed agonal breathing and PEA arrest. She was intubated and ACLS protocol was initiated. Lucas device was placed. Cath lab was contacted as well as surgical critical care attending. Decision was made to place patient on ECMO and she was transferred to the cath lab for further management. While in the cath lab, she was placed on VA ECMO via right femoral vessels. She was found to have a large saddle PE and occlusive Right PA pulmonary embolism and large clot burden in the left PA.  She underwent flow retriever with improvement in clot burden. She has significant OGT output with bloody output as well as evidence of lower GI bleed. She had a large hematoma in the left groin. She was started on epi 0.2, levo 0.3 and vaso 0.04. Vasopressin was increased to 0.08. She was resuscitated with blood products given profound anemia and coagulopathy. Her pressor requirement decreased slightly. Her neurologic exam was questionable with no movement to noxious stimuli. Her pupils were weakly reactive. She did not have a gag or cough reflex. She was breathing over the ventilator. Over the course of the next few hours, she continued to have significant pressor requirements and evidence of ongoing blood loss through her GI tract and Left  groin. She had a significant lactic acidosis that did not improve. CVVHD was initiated. Suddenly, her VA ECMO flows decreased significantly and venous pressures were high. The ECMO circuit was clamped and the venous cannula was interrogated. There was no flow from the venous cannula despite repositioning. She had evidence of mottling in her right lower extremity to her abdomen concerning for clot through the IVC. Given the suspected clot burden and lack of neurologic activity, further resuscitation was deemed futile. Family was contacted and patient was made CMO.  She subsequently expired 3/21 at 0455.
Age: 89.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Confusional state, Death, Influenza
Clinical narrative: Patient was admitted to the hospital 3/8/2021 and passed away 3/12/2021.
Age: 89.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Influenza B virus test positive, Oxygen saturation decreased, SARS-CoV-2 test positive
Clinical narrative: Patient was admitted to the hospital 3/8/2021 and passed away 3/12/2021.
Age: 89.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Death
Clinical narrative: Patient was admitted to the hospital 3/8/2021 and passed away 3/12/2021.
Age: 33.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia, Hypoaesthesia oral
Clinical narrative: Patient was seen at ER for left sided facial numbness at 2126 on 22 MAR. Patient was diagnosed w/ paresthesia and discharged at 2200 on 22 MAR.
Age: 33.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia, Paraesthesia
Clinical narrative: Patient was seen at ER for left sided facial numbness at 2126 on 22 MAR. Patient was diagnosed w/ paresthesia and discharged at 2200 on 22 MAR.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arrhythmia, Balance disorder, Chest pain, Fatigue, Influenza like illness
Clinical narrative: Within 3 days had severe itching all over including eyes, scalp and legs, antihistamines did not work, flu like feeling, felt bad all over, spent alot of time in bed or recliner, fatigue with no energy, heart arrhythmia, Dr. ordered heart monitor to be worn, chest pain, occasional body tremors and off balance, no rash, somewhat improved almost a month later
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Palpitations, Pruritus, Tremor
Clinical narrative: Within 3 days had severe itching all over including eyes, scalp and legs, antihistamines did not work, flu like feeling, felt bad all over, spent alot of time in bed or recliner, fatigue with no energy, heart arrhythmia, Dr. ordered heart monitor to be worn, chest pain, occasional body tremors and off balance, no rash, somewhat improved almost a month later
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arrhythmia, Balance disorder, Cardiac monitoring, Chest pain, Electrocardiogram
Clinical narrative: Within 3 days had severe itching all over including eyes, scalp and legs, antihistamines did not work, flu like feeling, felt bad all over, spent alot of time in bed or recliner, fatigue with no energy, heart arrhythmia, Dr. ordered heart monitor to be worn, chest pain, occasional body tremors and off balance, no rash, somewhat improved almost a month later
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Eye pruritus, Fatigue, Feeling abnormal, Influenza like illness, Pruritus
Clinical narrative: Within 3 days had severe itching all over including eyes, scalp and legs, antihistamines did not work, flu like feeling, felt bad all over, spent alot of time in bed or recliner, fatigue with no energy, heart arrhythmia, Dr. ordered heart monitor to be worn, chest pain, occasional body tremors and off balance, no rash, somewhat improved almost a month later
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Tremor
Clinical narrative: Within 3 days had severe itching all over including eyes, scalp and legs, antihistamines did not work, flu like feeling, felt bad all over, spent alot of time in bed or recliner, fatigue with no energy, heart arrhythmia, Dr. ordered heart monitor to be worn, chest pain, occasional body tremors and off balance, no rash, somewhat improved almost a month later
Age: 47.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Chills, Electroencephalogram normal, Fatigue, Headache, Hypoaesthesia
Clinical narrative: GBS weakness
Age: 47.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Hyporesponsive to stimuli, Lumbar puncture normal, Magnetic resonance imaging head normal, Malaise, Musculoskeletal stiffness
Clinical narrative: GBS weakness
Age: 47.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Nerve conduction studies normal, Post lumbar puncture syndrome, Pyrexia, Urinary incontinence
Clinical narrative: GBS weakness
Age: 47.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Asthenia, Guillain-Barre syndrome
Clinical narrative: GBS weakness
Age: 47.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Back pain, Blood test, CSF test, Deafness, Guillain-Barre syndrome
Clinical narrative: GBS weakness
Age: 47.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Headache, Hemiparesis, Hypertension, Hypoaesthesia, Loss of consciousness
Clinical narrative: GBS weakness
Age: 47.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Magnetic resonance imaging, Neck pain, Pyrexia, Weight
Clinical narrative: GBS weakness
Age: 74.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Death
Clinical narrative: Patient had an ED visit and/or hospitalization within 6 weeks of receiving COVID vaccine.
Age: 20.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood test, Catheterisation cardiac normal, Chest pain, Computerised tomogram abnormal, Echocardiogram abnormal
Clinical narrative: Myocarditis
Age: 20.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Electrocardiogram ST segment depression, Electrocardiogram ST segment elevation, Myocarditis, Pericarditis, Troponin increased
Clinical narrative: Myocarditis
Age: 20.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Catheterisation cardiac, Electrocardiogram change, Myocarditis, Troponin increased
Clinical narrative: Myocarditis
Age: 20.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Chest pain, Dyspnoea, Electrocardiogram ST segment depression, Electrocardiogram ST segment elevation, Myocarditis
Clinical narrative: Myocarditis
Age: 20.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Troponin I increased
Clinical narrative: Myocarditis
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Dyspnoea, Intensive care, Swollen tongue
Clinical narrative: Anaphylaxis   Symptoms: SHORTNESS OF BREATH(R0602).
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Dysphagia, Dyspnoea, Intensive care, Swelling face, Tongue pruritus
Clinical narrative: Anaphylaxis   Symptoms: SHORTNESS OF BREATH(R0602).
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Dyspnoea, Paraesthesia oral, Tachycardia, Throat tightness
Clinical narrative: Anaphylaxis   Symptoms: SHORTNESS OF BREATH(R0602).
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Anaphylactic reaction, Dyspnoea
Clinical narrative: Anaphylaxis   Symptoms: SHORTNESS OF BREATH(R0602).
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dysphagia, Hypersensitivity
Clinical narrative: 1. Throat swelling / numbness: Took Benedryl every 6 hours for 4 days before it subsided completely.  2. Shortness of breath - went on for 2 1/2 weeks. Had to limit activities to have less of reaction.  3. Hives / Rash - Was already taking benedryl which helped, but over the course of 4 weeks, hives / rash came back. Took Benedryl, and still not resolved.  4. Headache: Bad headache which was relieved with fiorinol and hydrocodone used for other headaches. Lasted 5 days and that headache resolved.  5. Fever: 101.3 lasted 3 days and resolved
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Headache, Loss of personal independence in daily activities, Pharyngeal hypoaesthesia, Rash
Clinical narrative: 1. Throat swelling / numbness: Took Benedryl every 6 hours for 4 days before it subsided completely.  2. Shortness of breath - went on for 2 1/2 weeks. Had to limit activities to have less of reaction.  3. Hives / Rash - Was already taking benedryl which helped, but over the course of 4 weeks, hives / rash came back. Took Benedryl, and still not resolved.  4. Headache: Bad headache which was relieved with fiorinol and hydrocodone used for other headaches. Lasted 5 days and that headache resolved.  5. Fever: 101.3 lasted 3 days and resolved
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Urticaria
Clinical narrative: 1. Throat swelling / numbness: Took Benedryl every 6 hours for 4 days before it subsided completely.  2. Shortness of breath - went on for 2 1/2 weeks. Had to limit activities to have less of reaction.  3. Hives / Rash - Was already taking benedryl which helped, but over the course of 4 weeks, hives / rash came back. Took Benedryl, and still not resolved.  4. Headache: Bad headache which was relieved with fiorinol and hydrocodone used for other headaches. Lasted 5 days and that headache resolved.  5. Fever: 101.3 lasted 3 days and resolved
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Metabolic disorder, Muscle tightness, Myalgia
Clinical narrative: arms and legs and shoulders, pain so bad it is debilitating; arms and legs and shoulders, pain so bad it is debilitating; arms and legs and shoulders, pain so bad it is debilitating; cant hardly walk; whole body muscle pain; This is a spontaneous report from a contactable consumer (patient). A 64-year-old male patient received the first dose of bnt162b2, via an unspecified route of administration, administered in Left arm on 15Mar2021 11:00 (Lot Number: EN6205) as single dose for covid-19 immunisation. There were no medical history and concomitant medications. To start, nothing. About 4 days after the shot experienced whole body muscle pain (19Mar2021 10:00). Lasted about 3-4 days and eased up, never went completely away, for 3-4 days then came back again. Eased up and came back. Suggested go to ER. Went to ER. spent the day. Urine and blood samples. They did not know what is wrong with him. It is vaccine related. Severe muscle pains now all day long every day and worse every day. Woke him up at 4:30 am this morning. Muscles hurt so bad was barely able to get out of bed, cant hardly walk on 15Apr2021 4:30. No other symptoms. Arms and legs and shoulders, pain so bad it is debilitating. When his wife and he went for the 2nd shot, he was denied due to symptoms and went and took a rapid and regular (Nasal Swab) covid test both Negative (05Apr2021). Had great health, just retired. Events resulted in Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Hospitalization (1 day), Disability or permanent damage. No treatment received. The outcome of the events was not recovered.
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Arthralgia, Asthenia, Blood test, Gait inability, Myalgia
Clinical narrative: arms and legs and shoulders, pain so bad it is debilitating; arms and legs and shoulders, pain so bad it is debilitating; arms and legs and shoulders, pain so bad it is debilitating; cant hardly walk; whole body muscle pain; This is a spontaneous report from a contactable consumer (patient). A 64-year-old male patient received the first dose of bnt162b2, via an unspecified route of administration, administered in Left arm on 15Mar2021 11:00 (Lot Number: EN6205) as single dose for covid-19 immunisation. There were no medical history and concomitant medications. To start, nothing. About 4 days after the shot experienced whole body muscle pain (19Mar2021 10:00). Lasted about 3-4 days and eased up, never went completely away, for 3-4 days then came back again. Eased up and came back. Suggested go to ER. Went to ER. spent the day. Urine and blood samples. They did not know what is wrong with him. It is vaccine related. Severe muscle pains now all day long every day and worse every day. Woke him up at 4:30 am this morning. Muscles hurt so bad was barely able to get out of bed, cant hardly walk on 15Apr2021 4:30. No other symptoms. Arms and legs and shoulders, pain so bad it is debilitating. When his wife and he went for the 2nd shot, he was denied due to symptoms and went and took a rapid and regular (Nasal Swab) covid test both Negative (05Apr2021). Had great health, just retired. Events resulted in Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Hospitalization (1 day), Disability or permanent damage. No treatment received. The outcome of the events was not recovered.
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pain in extremity, SARS-CoV-2 test, Urine analysis
Clinical narrative: arms and legs and shoulders, pain so bad it is debilitating; arms and legs and shoulders, pain so bad it is debilitating; arms and legs and shoulders, pain so bad it is debilitating; cant hardly walk; whole body muscle pain; This is a spontaneous report from a contactable consumer (patient). A 64-year-old male patient received the first dose of bnt162b2, via an unspecified route of administration, administered in Left arm on 15Mar2021 11:00 (Lot Number: EN6205) as single dose for covid-19 immunisation. There were no medical history and concomitant medications. To start, nothing. About 4 days after the shot experienced whole body muscle pain (19Mar2021 10:00). Lasted about 3-4 days and eased up, never went completely away, for 3-4 days then came back again. Eased up and came back. Suggested go to ER. Went to ER. spent the day. Urine and blood samples. They did not know what is wrong with him. It is vaccine related. Severe muscle pains now all day long every day and worse every day. Woke him up at 4:30 am this morning. Muscles hurt so bad was barely able to get out of bed, cant hardly walk on 15Apr2021 4:30. No other symptoms. Arms and legs and shoulders, pain so bad it is debilitating. When his wife and he went for the 2nd shot, he was denied due to symptoms and went and took a rapid and regular (Nasal Swab) covid test both Negative (05Apr2021). Had great health, just retired. Events resulted in Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Hospitalization (1 day), Disability or permanent damage. No treatment received. The outcome of the events was not recovered.
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Arthralgia, C-reactive protein increased, Computerised tomogram, Gait disturbance, Groin pain
Clinical narrative: arms and legs and shoulders, pain so bad it is debilitating; arms and legs and shoulders, pain so bad it is debilitating; arms and legs and shoulders, pain so bad it is debilitating; cant hardly walk; whole body muscle pain; This is a spontaneous report from a contactable consumer (patient). A 64-year-old male patient received the first dose of bnt162b2, via an unspecified route of administration, administered in Left arm on 15Mar2021 11:00 (Lot Number: EN6205) as single dose for covid-19 immunisation. There were no medical history and concomitant medications. To start, nothing. About 4 days after the shot experienced whole body muscle pain (19Mar2021 10:00). Lasted about 3-4 days and eased up, never went completely away, for 3-4 days then came back again. Eased up and came back. Suggested go to ER. Went to ER. spent the day. Urine and blood samples. They did not know what is wrong with him. It is vaccine related. Severe muscle pains now all day long every day and worse every day. Woke him up at 4:30 am this morning. Muscles hurt so bad was barely able to get out of bed, cant hardly walk on 15Apr2021 4:30. No other symptoms. Arms and legs and shoulders, pain so bad it is debilitating. When his wife and he went for the 2nd shot, he was denied due to symptoms and went and took a rapid and regular (Nasal Swab) covid test both Negative (05Apr2021). Had great health, just retired. Events resulted in Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Hospitalization (1 day), Disability or permanent damage. No treatment received. The outcome of the events was not recovered.
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Muscle atrophy, Muscle injury, Muscular weakness, Pain in extremity, SARS-CoV-2 test
Clinical narrative: arms and legs and shoulders, pain so bad it is debilitating; arms and legs and shoulders, pain so bad it is debilitating; arms and legs and shoulders, pain so bad it is debilitating; cant hardly walk; whole body muscle pain; This is a spontaneous report from a contactable consumer (patient). A 64-year-old male patient received the first dose of bnt162b2, via an unspecified route of administration, administered in Left arm on 15Mar2021 11:00 (Lot Number: EN6205) as single dose for covid-19 immunisation. There were no medical history and concomitant medications. To start, nothing. About 4 days after the shot experienced whole body muscle pain (19Mar2021 10:00). Lasted about 3-4 days and eased up, never went completely away, for 3-4 days then came back again. Eased up and came back. Suggested go to ER. Went to ER. spent the day. Urine and blood samples. They did not know what is wrong with him. It is vaccine related. Severe muscle pains now all day long every day and worse every day. Woke him up at 4:30 am this morning. Muscles hurt so bad was barely able to get out of bed, cant hardly walk on 15Apr2021 4:30. No other symptoms. Arms and legs and shoulders, pain so bad it is debilitating. When his wife and he went for the 2nd shot, he was denied due to symptoms and went and took a rapid and regular (Nasal Swab) covid test both Negative (05Apr2021). Had great health, just retired. Events resulted in Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Hospitalization (1 day), Disability or permanent damage. No treatment received. The outcome of the events was not recovered.
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Weight decreased
Clinical narrative: arms and legs and shoulders, pain so bad it is debilitating; arms and legs and shoulders, pain so bad it is debilitating; arms and legs and shoulders, pain so bad it is debilitating; cant hardly walk; whole body muscle pain; This is a spontaneous report from a contactable consumer (patient). A 64-year-old male patient received the first dose of bnt162b2, via an unspecified route of administration, administered in Left arm on 15Mar2021 11:00 (Lot Number: EN6205) as single dose for covid-19 immunisation. There were no medical history and concomitant medications. To start, nothing. About 4 days after the shot experienced whole body muscle pain (19Mar2021 10:00). Lasted about 3-4 days and eased up, never went completely away, for 3-4 days then came back again. Eased up and came back. Suggested go to ER. Went to ER. spent the day. Urine and blood samples. They did not know what is wrong with him. It is vaccine related. Severe muscle pains now all day long every day and worse every day. Woke him up at 4:30 am this morning. Muscles hurt so bad was barely able to get out of bed, cant hardly walk on 15Apr2021 4:30. No other symptoms. Arms and legs and shoulders, pain so bad it is debilitating. When his wife and he went for the 2nd shot, he was denied due to symptoms and went and took a rapid and regular (Nasal Swab) covid test both Negative (05Apr2021). Had great health, just retired. Events resulted in Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Hospitalization (1 day), Disability or permanent damage. No treatment received. The outcome of the events was not recovered.
Age: 65.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Death
Clinical narrative: Patient presented to the ED and was subsequently hospitalized within 6 weeks of receiving COVID vaccination.
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea
Clinical narrative: Difficulty breathing
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest X-ray, Dyspnoea, SARS-CoV-2 test
Clinical narrative: Difficulty breathing
Age: 18.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood test normal, Disorganised speech, Electrocardiogram normal, Hypotension, Loss of consciousness
Clinical narrative: I passed out in the car.; My blood pressure was extremely low; I was pale and incoherent; I was pale and incoherent; This is a spontaneous report from a contactable consumer. An 18-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1 via an unspecified route of administration, administered in Arm Left on 08Apr2021 13:30 (Batch/Lot Number: ER8734) as SINGLE DOSE for covid-19 immunisation. The patient's medical history was reported as none. Pfizer shot was administered at 1:30 pm. The patient's mother decided to drive her car home. 10 minutes later the patient passed out in the car. The patient's mom called (Number) and paramedics transported her to the ER. The patient's blood pressure was extremely low, She was pale and incoherent. The patient underwent lab tests and procedures which included electrocardiogram: unknown result on an unspecified date.  Therapeutic measures were taken as a result of i passed out in the car, my blood pressure was extremely low, i was pale and incoherent, i was pale and incoherent: EKG, a bag of fluids and monitoring. The outcome of the events was recovered in Apr2021. The event passed out was assessed as serious (medically significant).
Age: 18.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pallor, Syncope
Clinical narrative: I passed out in the car.; My blood pressure was extremely low; I was pale and incoherent; I was pale and incoherent; This is a spontaneous report from a contactable consumer. An 18-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1 via an unspecified route of administration, administered in Arm Left on 08Apr2021 13:30 (Batch/Lot Number: ER8734) as SINGLE DOSE for covid-19 immunisation. The patient's medical history was reported as none. Pfizer shot was administered at 1:30 pm. The patient's mother decided to drive her car home. 10 minutes later the patient passed out in the car. The patient's mom called (Number) and paramedics transported her to the ER. The patient's blood pressure was extremely low, She was pale and incoherent. The patient underwent lab tests and procedures which included electrocardiogram: unknown result on an unspecified date.  Therapeutic measures were taken as a result of i passed out in the car, my blood pressure was extremely low, i was pale and incoherent, i was pale and incoherent: EKG, a bag of fluids and monitoring. The outcome of the events was recovered in Apr2021. The event passed out was assessed as serious (medically significant).
Age: 18.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Electrocardiogram, Hypotension, Incoherent, Loss of consciousness, Pallor
Clinical narrative: I passed out in the car.; My blood pressure was extremely low; I was pale and incoherent; I was pale and incoherent; This is a spontaneous report from a contactable consumer. An 18-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1 via an unspecified route of administration, administered in Arm Left on 08Apr2021 13:30 (Batch/Lot Number: ER8734) as SINGLE DOSE for covid-19 immunisation. The patient's medical history was reported as none. Pfizer shot was administered at 1:30 pm. The patient's mother decided to drive her car home. 10 minutes later the patient passed out in the car. The patient's mom called (Number) and paramedics transported her to the ER. The patient's blood pressure was extremely low, She was pale and incoherent. The patient underwent lab tests and procedures which included electrocardiogram: unknown result on an unspecified date.  Therapeutic measures were taken as a result of i passed out in the car, my blood pressure was extremely low, i was pale and incoherent, i was pale and incoherent: EKG, a bag of fluids and monitoring. The outcome of the events was recovered in Apr2021. The event passed out was assessed as serious (medically significant).
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest discomfort, Dizziness, Fatigue, Hypoaesthesia, Pain
Clinical narrative: This is a spontaneous report from a contactable consumer reporting for a patient. A 49-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Arm Left on 09Apr2021 11:00 (Batch/Lot Number: ER8737) as SINGLE DOSE for covid-19 immunisation, at 49 years old at other facility type. The patient is not pregnant at time of vaccination. Medical history included allergies to Rosemary from an unknown date. No other vaccine in four weeks were noted. Patient did not have COVID prior vaccination and was not tested for COVID post vaccination. Concomitant medications included cetirizine hydrochloride (ZYRTEC); propranolol hydrochloride (INDERAL); lorazepam (ATIVAN); hctz; quetiapine fumarate (SEROQUEL); gabapentin taken for an unspecified indication, start and stop date were not reported. The patient previously took macrobid [nitrofurantoin] and experienced allergies. The patient previously received the first dose of BNT162B2 (Lot number: ER8727) on 17Mar2021 13:00 (left arm) for COVID-19 immunisation. On 10 Apr2021, the patient experienced Itchy palms (reported as within hours), tachycardia, tightness in chest, difficulty breathing, tingling tongue and fingers, vomiting, confusion, dizzy, fainting, abdominal pain, severe pain everywhere, too fatigued to move. Patient tried to call ambulance but could not get phone or unlock the door. She stated she tried from 1 AM to 07:30 AM. After 07:30 AM she had expected effects of fever as well as fatigue and pain. The events resulted in Doctor or other healthcare professional office/clinic visit. Treatment was not given. Outcome of the events was recovered on an unspecified date.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Paraesthesia, Paraesthesia oral, Peripheral coldness, Pyrexia, Syncope
Clinical narrative: This is a spontaneous report from a contactable consumer reporting for a patient. A 49-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Arm Left on 09Apr2021 11:00 (Batch/Lot Number: ER8737) as SINGLE DOSE for covid-19 immunisation, at 49 years old at other facility type. The patient is not pregnant at time of vaccination. Medical history included allergies to Rosemary from an unknown date. No other vaccine in four weeks were noted. Patient did not have COVID prior vaccination and was not tested for COVID post vaccination. Concomitant medications included cetirizine hydrochloride (ZYRTEC); propranolol hydrochloride (INDERAL); lorazepam (ATIVAN); hctz; quetiapine fumarate (SEROQUEL); gabapentin taken for an unspecified indication, start and stop date were not reported. The patient previously took macrobid [nitrofurantoin] and experienced allergies. The patient previously received the first dose of BNT162B2 (Lot number: ER8727) on 17Mar2021 13:00 (left arm) for COVID-19 immunisation. On 10 Apr2021, the patient experienced Itchy palms (reported as within hours), tachycardia, tightness in chest, difficulty breathing, tingling tongue and fingers, vomiting, confusion, dizzy, fainting, abdominal pain, severe pain everywhere, too fatigued to move. Patient tried to call ambulance but could not get phone or unlock the door. She stated she tried from 1 AM to 07:30 AM. After 07:30 AM she had expected effects of fever as well as fatigue and pain. The events resulted in Doctor or other healthcare professional office/clinic visit. Treatment was not given. Outcome of the events was recovered on an unspecified date.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Tachycardia
Clinical narrative: This is a spontaneous report from a contactable consumer reporting for a patient. A 49-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Arm Left on 09Apr2021 11:00 (Batch/Lot Number: ER8737) as SINGLE DOSE for covid-19 immunisation, at 49 years old at other facility type. The patient is not pregnant at time of vaccination. Medical history included allergies to Rosemary from an unknown date. No other vaccine in four weeks were noted. Patient did not have COVID prior vaccination and was not tested for COVID post vaccination. Concomitant medications included cetirizine hydrochloride (ZYRTEC); propranolol hydrochloride (INDERAL); lorazepam (ATIVAN); hctz; quetiapine fumarate (SEROQUEL); gabapentin taken for an unspecified indication, start and stop date were not reported. The patient previously took macrobid [nitrofurantoin] and experienced allergies. The patient previously received the first dose of BNT162B2 (Lot number: ER8727) on 17Mar2021 13:00 (left arm) for COVID-19 immunisation. On 10 Apr2021, the patient experienced Itchy palms (reported as within hours), tachycardia, tightness in chest, difficulty breathing, tingling tongue and fingers, vomiting, confusion, dizzy, fainting, abdominal pain, severe pain everywhere, too fatigued to move. Patient tried to call ambulance but could not get phone or unlock the door. She stated she tried from 1 AM to 07:30 AM. After 07:30 AM she had expected effects of fever as well as fatigue and pain. The events resulted in Doctor or other healthcare professional office/clinic visit. Treatment was not given. Outcome of the events was recovered on an unspecified date.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain, Chest discomfort, Confusional state, Dizziness, Dyspnoea
Clinical narrative: This is a spontaneous report from a contactable consumer reporting for a patient. A 49-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Arm Left on 09Apr2021 11:00 (Batch/Lot Number: ER8737) as SINGLE DOSE for covid-19 immunisation, at 49 years old at other facility type. The patient is not pregnant at time of vaccination. Medical history included allergies to Rosemary from an unknown date. No other vaccine in four weeks were noted. Patient did not have COVID prior vaccination and was not tested for COVID post vaccination. Concomitant medications included cetirizine hydrochloride (ZYRTEC); propranolol hydrochloride (INDERAL); lorazepam (ATIVAN); hctz; quetiapine fumarate (SEROQUEL); gabapentin taken for an unspecified indication, start and stop date were not reported. The patient previously took macrobid [nitrofurantoin] and experienced allergies. The patient previously received the first dose of BNT162B2 (Lot number: ER8727) on 17Mar2021 13:00 (left arm) for COVID-19 immunisation. On 10 Apr2021, the patient experienced Itchy palms (reported as within hours), tachycardia, tightness in chest, difficulty breathing, tingling tongue and fingers, vomiting, confusion, dizzy, fainting, abdominal pain, severe pain everywhere, too fatigued to move. Patient tried to call ambulance but could not get phone or unlock the door. She stated she tried from 1 AM to 07:30 AM. After 07:30 AM she had expected effects of fever as well as fatigue and pain. The events resulted in Doctor or other healthcare professional office/clinic visit. Treatment was not given. Outcome of the events was recovered on an unspecified date.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Pain, Paraesthesia, Paraesthesia oral, Pruritus
Clinical narrative: This is a spontaneous report from a contactable consumer reporting for a patient. A 49-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Arm Left on 09Apr2021 11:00 (Batch/Lot Number: ER8737) as SINGLE DOSE for covid-19 immunisation, at 49 years old at other facility type. The patient is not pregnant at time of vaccination. Medical history included allergies to Rosemary from an unknown date. No other vaccine in four weeks were noted. Patient did not have COVID prior vaccination and was not tested for COVID post vaccination. Concomitant medications included cetirizine hydrochloride (ZYRTEC); propranolol hydrochloride (INDERAL); lorazepam (ATIVAN); hctz; quetiapine fumarate (SEROQUEL); gabapentin taken for an unspecified indication, start and stop date were not reported. The patient previously took macrobid [nitrofurantoin] and experienced allergies. The patient previously received the first dose of BNT162B2 (Lot number: ER8727) on 17Mar2021 13:00 (left arm) for COVID-19 immunisation. On 10 Apr2021, the patient experienced Itchy palms (reported as within hours), tachycardia, tightness in chest, difficulty breathing, tingling tongue and fingers, vomiting, confusion, dizzy, fainting, abdominal pain, severe pain everywhere, too fatigued to move. Patient tried to call ambulance but could not get phone or unlock the door. She stated she tried from 1 AM to 07:30 AM. After 07:30 AM she had expected effects of fever as well as fatigue and pain. The events resulted in Doctor or other healthcare professional office/clinic visit. Treatment was not given. Outcome of the events was recovered on an unspecified date.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pyrexia, Syncope, Tachycardia, Vomiting
Clinical narrative: This is a spontaneous report from a contactable consumer reporting for a patient. A 49-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Arm Left on 09Apr2021 11:00 (Batch/Lot Number: ER8737) as SINGLE DOSE for covid-19 immunisation, at 49 years old at other facility type. The patient is not pregnant at time of vaccination. Medical history included allergies to Rosemary from an unknown date. No other vaccine in four weeks were noted. Patient did not have COVID prior vaccination and was not tested for COVID post vaccination. Concomitant medications included cetirizine hydrochloride (ZYRTEC); propranolol hydrochloride (INDERAL); lorazepam (ATIVAN); hctz; quetiapine fumarate (SEROQUEL); gabapentin taken for an unspecified indication, start and stop date were not reported. The patient previously took macrobid [nitrofurantoin] and experienced allergies. The patient previously received the first dose of BNT162B2 (Lot number: ER8727) on 17Mar2021 13:00 (left arm) for COVID-19 immunisation. On 10 Apr2021, the patient experienced Itchy palms (reported as within hours), tachycardia, tightness in chest, difficulty breathing, tingling tongue and fingers, vomiting, confusion, dizzy, fainting, abdominal pain, severe pain everywhere, too fatigued to move. Patient tried to call ambulance but could not get phone or unlock the door. She stated she tried from 1 AM to 07:30 AM. After 07:30 AM she had expected effects of fever as well as fatigue and pain. The events resulted in Doctor or other healthcare professional office/clinic visit. Treatment was not given. Outcome of the events was recovered on an unspecified date.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Erythema, Injection site erythema, Injection site scar, Scar, Urticaria
Clinical narrative: Patient had scarring on her left deltoid from the first dose of the vaccine.  Dose #2 - approximately 5-6 days post vaccine, patient noticed rash/hives on neck, itching.  The patient also had red patches on her left arm (injection site for dose #2).  The patient also complained of fatigue, headache, muscle/joint pain, chills, fever, very swollen and red injection site.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Chills, Fatigue, Headache, Injection site erythema
Clinical narrative: Patient had scarring on her left deltoid from the first dose of the vaccine.  Dose #2 - approximately 5-6 days post vaccine, patient noticed rash/hives on neck, itching.  The patient also had red patches on her left arm (injection site for dose #2).  The patient also complained of fatigue, headache, muscle/joint pain, chills, fever, very swollen and red injection site.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Injection site swelling, Myalgia, Pruritus, Pyrexia, Rash
Clinical narrative: Patient had scarring on her left deltoid from the first dose of the vaccine.  Dose #2 - approximately 5-6 days post vaccine, patient noticed rash/hives on neck, itching.  The patient also had red patches on her left arm (injection site for dose #2).  The patient also complained of fatigue, headache, muscle/joint pain, chills, fever, very swollen and red injection site.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Urticaria
Clinical narrative: Patient had scarring on her left deltoid from the first dose of the vaccine.  Dose #2 - approximately 5-6 days post vaccine, patient noticed rash/hives on neck, itching.  The patient also had red patches on her left arm (injection site for dose #2).  The patient also complained of fatigue, headache, muscle/joint pain, chills, fever, very swollen and red injection site.
Age: 40.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Feeling abnormal, Headache, Impaired work ability, Pain
Clinical narrative: Brain fog; Dizziness; This is a spontaneous report from a contactable consumer (patient). A 40-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number and expiration date were not reported) on the left arm on 05Apr2021 (10:30) as a single dose, with route of administration unspecified, for COVID-19 immunization. The patient's medical history was not reported. Concomitant medications included venlafaxine hydrochloride (EFFEXOR), allopurinol, omeprazole (PRILOSEC) and lorazepam. The patient had previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number and expiration date were not reported) on the left arm on 15Mar2021 (when the patient was 40 years old) for COVID-19 immunization. On 05Apr2021 (14:00), the patient had brain fog and dizziness. The events had resulted into doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care, and were reported to be serious (causing disability or permanent damage). The patient did not receive any treatment for the reported events. The outcome of the events was not recovered. The patient was not diagnosed with COVID-19 prior to vaccination, and had not been tested post-vaccination.  Information on the lot/batch number has been requested.
Age: 40.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pyrexia
Clinical narrative: Brain fog; Dizziness; This is a spontaneous report from a contactable consumer (patient). A 40-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number and expiration date were not reported) on the left arm on 05Apr2021 (10:30) as a single dose, with route of administration unspecified, for COVID-19 immunization. The patient's medical history was not reported. Concomitant medications included venlafaxine hydrochloride (EFFEXOR), allopurinol, omeprazole (PRILOSEC) and lorazepam. The patient had previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number and expiration date were not reported) on the left arm on 15Mar2021 (when the patient was 40 years old) for COVID-19 immunization. On 05Apr2021 (14:00), the patient had brain fog and dizziness. The events had resulted into doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care, and were reported to be serious (causing disability or permanent damage). The patient did not receive any treatment for the reported events. The outcome of the events was not recovered. The patient was not diagnosed with COVID-19 prior to vaccination, and had not been tested post-vaccination.  Information on the lot/batch number has been requested.